CCT

TransBiotec, Inc. releases salary data. CEO sees compensation fall -24%

TransBiotec, Inc. just filed its annual proxy statement, which details the salary information of its key executives. In 2020, the company's CEO made 213,000.

The table is included below:






















































































































































































































































































































































































































































SUMMARY COMPENSATION TABLE





Name


and Principal


Position








Year








Salary




($)

(1)











Bonus




($)








Stock




Awards




($)








Option




Awards




($)

(9)











Non-Equity




Incentive




Plan




Compensa


tion




($)






Change in




Pension




Value and




Nonqualified




Deferred




Compensation


Earnings




($)








All




Other




Compensa


tion




($)











Total




($)





Kevin Moore,





2020







213,000








-0-





-0-





-0-








-0-





-0-






-0-










213,000





CEO

(2)(11)





2019







39,508








-0-





-0-







240,779








-0-





-0-






-0-










280,287




















































































David Gandini,





2020







185,000








-0-





-0-






-0-








-0-





-0-






-0-










185,000





CFO, CRO and Secretary

(3)





2019







29,417








-0-





-0-







215,018








-0-





-0-






-0-










244,435




















































































Dean Watson, CTO

(10)





2020







43,750








-0-





-0-






-0-








-0-





-0-






-0-










43,750




















































































Charles Bennington
















































































Former Chief Executive Officer,





2020







50,000

(5)





-0-





-0-






-0-








-0-





-0-






-0-










50,000

(5)


CFO, and Secretary

(4)





2019






-0-








-0-





-0-







4,163








-0-





-0-







60,000

(6)







64,163






















































































Nick Noceti, Former CFO

(7)





2020







16,500

(8)





-0-





-0-






-0-








-0-





-0-






-0-










16,500

(8)








2019






-0-








-0-





-0-







4,163








-0-





-0-







66,000

(8)







70,163

(8)

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever TransBiotec, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

TransBiotec, Inc. director just picked up 11,765 shares - June 21, 2022
TransBiotec, Inc. director just declared ownership of no shares of TransBiotec, Inc. - June 15, 2022
TransBiotec, Inc.'s CFO just declared ownership of no shares of TransBiotec, Inc. - June 13, 2022
TransBiotec, Inc.'s CFO just picked up 11,765 shares - June 13, 2022

Auto Refresh

Feedback